|
Pronunciation |
|
(hye
droe floo meth EYE a zide &
re SER peen) |

|
|
U.S. Brand
Names |
|
Salutensin® |

|
|
Generic
Available |
|
Yes |

|
|
Synonyms |
|
reserpine and hydroflumethiazide |

|
|
Pharmacological Index |
|
Antihypertensive Agent, Combination |

|
|
Use |
|
Management of hypertension |

|
|
Pregnancy Risk
Factor |
|
C |

|
|
Usual Dosage |
|
As determined by individual titration, usually 1 tablet once or twice
daily |

|
|
Cardiovascular
Considerations |
|
Combination therapy for the treatment of hypertension should be
individualized for each patient. Potential advantages for hydroflumethiazide and
reserpine combination therapy may include improved compliance and synergistic
reductions in blood pressure with an accompanied reduction in side effects.
Thiazide therapy improves cardiovascular outcomes in patients with hypertension.
Reserpine is infrequently used alone for the treatment of hypertension due to
possible side effects. |

|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |

|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |

|
|
Dosage Forms |
|
Tablet (Salutensin®): Hydroflumethiazide 50 mg and
reserpine 0.125 mg
Tablet (Hydro-Fluserpine®,
Salutensin-Demi®): Hydroflumethiazide 25 mg and reserpine
0.125 mg |

|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|